Monitoring and treatment of alcohol use disorder: an integrated multidisciplinary model

Abstract

Alcohol-associated liver disease (ALD) is one of the most prevalent liver diseases and a leading indication for liver transplantation (LT). Alcohol use disorder (AUD), commonly present in patients with ALD, may also be associated with psychiatric comorbidities such as depression and anxiety. Early identification of ALD and timely treatment of AUD can help prevent the progression to advanced stages of ALD, including cirrhosis and alcoholic hepatitis. However, screening for alcohol use and managing AUD in ALD patients are often not performed due to various barriers at the patient, clinician, and administrative levels. This review highlights an integrated multidisciplinary care model, emphasizing the roles of hepatologists, psychiatrists, addiction counselors, and social workers in providing comprehensive management of both liver disease and AUD. It outlines laboratory assessments, pharmacological and behavioral therapies, and recommended follow-up evaluations by specialists. The goal of this article is to promote team-based comprehensive care for patients with ALD.

Keywords

AH / alcohol / ALD / AUD / cirrhosis / depression / LT

References

[1] Singal AK.Diagnosis and treatment of alcohol-associated liver disease: a review.JAMA2021;326:165-76

[2] Singal AK,Dunn W.Alcohol-associated liver disease in the United States is associated with severe forms of disease among young, females and Hispanics.Aliment Pharmacol Ther2021;54:451-61

[3] Arab JP,Thiele M,Wong RJ.Alcohol-associated liver disease: managing the dual pathology of liver disease and of alcohol use disorder.Gastroenterology2025;168:231-44.e2

[4] Hasin DS,Auriacombe M.DSM-5 criteria for substance use disorders: recommendations and rationale.AJP2013;170:834-51 PMCID:PMC3767415

[5] Louvet A,Artru F.Main drivers of outcome differ between short term and long term in severe alcoholic hepatitis: a prospective study.Hepatology2017;66:1464-73

[6] Kodali S,Tariq R.Alcohol relapse after liver transplantation for alcoholic cirrhosis-impact on liver graft and patient survival: a meta-analysis.Alcohol Alcohol2018;53:166-72

[7] Rogal S,Zhang H.Impact of alcohol use disorder treatment on clinical outcomes among patients with cirrhosis.Hepatology2020;71:2080-92 PMCID:PMC8032461

[8] Vannier AGL,Fomin V.Incidence and progression of alcohol-associated liver disease after medical therapy for alcohol use disorder.JAMA Netw Open2022;5:e2213014 PMCID:PMC9123494

[9] Hu H,Han Y.Prevalence and treatment for alcohol use disorders based on kentucky medicaid 2012-2019 datasets.J Alcohol Drug Depend2022;10:1000366 PMCID:PMC9850928

[10] DiMartini AF,Singal AK.Barriers to the management of alcohol use disorder and alcohol-associated liver disease: strategies to implement integrated care models.Lancet Gastroenterol Hepatol2022;7:186-95

[11] Mellinger JL,Shedden K.Gender disparities in alcohol use disorder treatment among privately insured patients with alcohol-associated cirrhosis.Alcohol Clin Exp Res2019;43:334-41 PMCID:PMC6379081

[12] Keyes KM,McLaughlin KA.Stigma and treatment for alcohol disorders in the United States.Am J Epidemiol2010;172:1364-72 PMCID:PMC2998202

[13] Singal AK,DiMartini A.Alcohol use disorder in alcohol-associated liver disease: two sides of the same coin.Liver Transpl2024;30:200-12

[14] Lennon-Dearing R,Garrett L,Abercrombie S.A rural community-based interdisciplinary curriculum: a social work perspective.Soc Work Health Care2008;47:93-107

[15] Wong RJ.Trends in liver disease etiology among adults awaiting liver transplantation in the United States, 2014-2019.JAMA Netw Open2020;3:e1920294

[16] Axley PD,Singal AK.Epidemiology of alcohol consumption and societal burden of alcoholism and alcoholic liver disease.Clin Liver Dis2019;23:39-50

[17] Fuster D.Alcohol use in patients with chronic liver disease.N Engl J Med2018;379:1251-61

[18] Singal AK,Wong RJ.Increasing burden of acute-on-chronic liver failure among alcohol-associated liver disease in the young population in the United States.Am J Gastroenterol2020;115:88-95

[19] Jurewicz I.Mental health in young adults and adolescents - supporting general physicians to provide holistic care.Clin Med2015;15:151-4 PMCID:PMC4953734

[20] Tarantino G,Citro V.Could alcohol abuse and dependence on junk foods inducing obesity and/or illicit drug use represent danger to liver in young people with altered psychological/relational spheres or emotional problems?.Int J Mol Sci2022;23:10406 PMCID:PMC9499369

[21] Shoreibah M,Bloomer J.Alcoholic liver disease presents at advanced stage and progresses faster compared to non-alcoholic fatty liver diseas.Ann Hepatol2016;15:183-9

[22] Saraireh H,Abdelfattah T.Training of hepatology providers improves the screening and resultant interventions for alcohol use disorder.Liver Int2020;40:2090-4

[23] Wong RJ,Cheung R.Impact of longitudinal alcohol use patterns on long-term risk of cirrhosis among US veterans with steatotic liver disease.Gastroenterology2024;166:1156-65.e4

[24] Im GY,Winters A.Provider attitudes and practices for alcohol screening, treatment, and education in patients with liver disease: a survey from the american association for the study of liver diseases alcohol-associated liver disease special interest group.Clin Gastroenterol Hepatol2021;19:2407-16.e8 PMCID:PMC8291372

[25] Kaner EF,Beyer F.The effectiveness of brief alcohol interventions in primary care settings: a systematic review.Drug Alcohol Rev2009;28:301-23

[26] Moyer VA; Preventive Services Task Force. Screening and behavioral counseling interventions in primary care to reduce alcohol misuse: U.S. preventive services task force recommendation statement.Ann Intern Med2013;159:210-8

[27] Kranzler HR.Diagnosis and pharmacotherapy of alcohol use disorder: a review.JAMA2018;320:815-24 PMCID:PMC7391072

[28] Louvet A, Labreuche J, Moreno C, et al; QuickTrans trial study group. Early liver transplantation for severe alcohol-related hepatitis not responding to medical treatment: a prospective controlled study. Lancet Gastroenterol Hepatol. 2022;7:416-25.

[29] Sobell LC, Sobell MB. Timeline follow-back. In: Litten RZ, Allen JP, Editors. Measuring alcohol consumption. Totowa, NJ: Humana Press; 1992.

[30] Kulkarni AV.Screening for alcohol use disorder and monitoring for alcohol use in the liver clinic.Clin Liver Dis2023;22:219-24 PMCID:PMC10745230

[31] Evidence-based practices in writing. Available from: https://www.silvereye.com.au/documents/sample_pages/prod9580.pdf. [Last accessed on 19 Mar 2025].

[32] McHugh RK,Otto MW.Cognitive behavioral therapy for substance use disorders.Psychiatr Clin North Am2010;33:511-25 PMCID:PMC2897895

[33] Morey LC.Patient placement criteria: linking typologies to managed care.Alcohol Health Res World1996;20:36-44 PMCID:PMC6876533

[34] Chuang E,Alexander JA,Lee IH.Factors associated with use of ASAM criteria and service provision in a national sample of outpatient substance abuse treatment units.J Addict Med2009;3:139-50 PMCID:PMC3584172

[35] Ayyala D,Tien C.Naltrexone for alcohol use disorder: hepatic safety in patients with and without liver disease.Hepatol Commun2022;6:3433-42 PMCID:PMC9701476

[36] Caputo F,Bernardi M.Diagnosis and treatment of alcohol use disorder in patients with end-stage alcoholic liver disease.Hepatology2019;70:410-7

[37] Burnette EM,Grodin EN.Novel agents for the pharmacological treatment of alcohol use disorder.Drugs2022;82:251-74 PMCID:PMC8888464

[38] Leggio L.Treatment of alcohol use disorder in patients with alcoholic liver disease.Am J Med2017;130:124-34 PMCID:PMC5263063

[39] Addolorato G,Ferrulli A.Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.Lancet2007;370:1915-22

[40] Grant BF,Saha TD.Epidemiology of DSM-5 alcohol use disorder: results from the national epidemiologic survey on alcohol and related conditions III.JAMA Psychiatry2015;72:757-66 PMCID:PMC5240584

[41] Stinson FS,Dawson DA,Huang B.Comorbidity between DSM-IV alcohol and specific drug use disorders in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions.Drug Alcohol Depend2005;80:105-16

[42] Singal AK,Leggio L,Kuo YF.Identifying alcohol use disorder in patients with cirrhosis reduces 30-days readmission rate.Alcohol Alcohol2022;57:576-80 PMCID:PMC9465529

[43] Elfeki MA,Leggio L.Simultaneous management of alcohol use disorder and liver disease: a systematic review and meta-analysis.J Addict Med2023;17:e119-28

[44] Mellinger JL,DeJonckheere M.Misconceptions, preferences and barriers to alcohol use disorder treatment in alcohol-related cirrhosis.J Subst Abuse Treat2018;91:20-7

[45] Rabiee A,Falker C,Taddei T.Medications for alcohol use disorder improve survival in patients with hazardous drinking and alcohol-associated cirrhosis.Hepatol Commun2023;7:e0093 PMCID:PMC10043587

[46] Gratacós-Ginès J,Pérez-Guasch M.Medications for alcohol use disorder promote abstinence in alcohol-associated cirrhosis: results from a systematic review and meta-analysis.Hepatology2024;79:368-79

[47] Lucey MR.Integrated treatment of alcohol use disorder in patients with alcohol-associated liver disease: an evolving story.Hepatology2020;71:1891-3

[48] Szerman N, Torrens M, Maldonado R, et al; World Association on Dual Disorders (WADD). Addictive and other mental disorders: a call for a standardized definition of dual disorders. Transl Psychiatry. 2022;12:446. PMCID:PMC9562408

[49] DeMartini KS,Palmer A.Text messaging to reduce alcohol relapse in prelisting liver transplant candidates: a pilot feasibility study.Alcohol Clin Exp Res2018;42:761-9 PMCID:PMC6438371

[50] Addolorato G, Mirijello A, Leggio L, et al; Gemelli OLT Group. Liver transplantation in alcoholic patients: impact of an alcohol addiction unit within a liver transplant center. Alcohol Clin Exp Res. 2013;37:1601-8. PMCID:PMC4977094

[51] Carrique L,Tan A.Results of early transplantation for alcohol-related cirrhosis: integrated addiction treatment with low rate of relapse.Gastroenterology2021;161:1896-06.e2

[52] Daniel J,Del Bello A.Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse.JHEP Rep2023;5:100832 PMCID:PMC10480527

[53] Avanceña ALV,Uttal SE,Mellinger JL.Cost-effectiveness of alcohol use treatments in patients with alcohol-related cirrhosis.J Hepatol2021;74:1286-94 PMCID:PMC8177741

[54] Lucey MR,Mellinger JL,Crabb DW.Introducing the 2019 American association for the study of liver diseases guidance on alcohol-associated liver disease.Liver Transpl2020;26:14-6

[55] Singal AK,Ahn J,Shah VH.ACG clinical guideline: alcoholic liver disease.Am J Gastroenterol2018;113:175-94 PMCID:PMC6524956

[56] Jophlin LL,Bataller R.ACG clinical guideline: alcohol-associated liver disease.Am J Gastroenterol2024;119:30-54 PMCID:PMC11040545

[57] Association for the Study of the Liver. EASL clinical practice guidelines: management of alcohol-related liver disease.J Hepatol2018;69:154-81

[58] Russ KB,Kamath PS,Kuo YF.Alcohol use after liver transplantation is independent of liver disease etiology.Alcohol Alcohol2016;51:698-701 PMCID:PMC5091294

[59] Moreno C,Szabo G.Non-invasive diagnosis and biomarkers in alcohol-related liver disease.J Hepatol2019;70:273-83

[60] Hazelden Betty Ford Graduate School. What is an addiction counselor? Available from: https://www.hazeldenbettyford.org/graduate-school-addiction-studies/what-are-addiction-counselors. [Last accessed on 19 Mar 2025].

[61] Papadimitriou G.The “Biopsychosocial Model”: 40 years of application in psychiatry.Psychiatriki2017;28:107-10

[62] Saxe Zerden L, Lombardi BM, Jones A. Social workers in integrated health care: improving care throughout the life course.Soc Work Health Care2019;58:142-9

[63] Dixie B. The impact of the biosound therapy system on post-acute withdrawal syndrome. Ph.D. Dissertation, the Faculty of Saybrook University, California, CA, 2018. Available from https://www.proquest.com/openview/b8441041beb904fef2e6bbfc7e024a58/1?pq-origsite=gscholar&cbl=18750&diss=y. [Last accessed on 17 Mar 2025].